Therapeutic Options for Establised or Recurrent Atrial Fibrillation: Focus on Antithrombotic Therapy
A stroke at any time may be devastating, This is just as true after heart surgery. Recognized perioperative cerebrovascular accidents, with a permanent deficit, occur in approximately three percent of patients undergoing coronary artery bypass graft surgery. Another three percent develop seizures or deterioration of neurologic function [1-3] (Table 1). Following valve surgery, the rates of embolic events are slightly higher (with over 90% of the emboli involving the brain) [4-7] (Table 1). Emboli from manipulation of atherosclerotic aortas probably explain a majority of these neurologic events;  some may be due to thromboemboli.
KeywordsAtrial Fibrillation Stroke Prevention Coronary Artery Bypass Graft Surgery Atrial Fibrillation Patient Antithrombotic Therapy
Unable to display preview. Download preview PDF.
- 2.Newman, MF, Wolman R, Kanchuger M, Marschall K, Mora-Mangano C. Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. American Heart Association, Inc. 1996; II-74–II-80.Google Scholar
- 4.Heras M, Chesebro JH, Fuster V, Penny W, Grill D. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. JACC 1995;11:1111–1119.Google Scholar
- 5.Davis EA, Greene PS, Cameron DE, Gott VL, Laschinger JC. Bioprosthetic versus mechanical prostheses for aortic valve replacement in the elderly. Circulation 1996;94:II-121–II-125.Google Scholar
- 6.Borger MA, Ivanov J, Weisel RD, Peniston CM, Mickleborough LL. Decreasing incidence of stroke during valvular surgery. Circulation 1998; II-137–II-143.Google Scholar
- 7.Moinudden K, Quin J, Shaw R, Dewar M, Tellides G. Anticoagulation is unnecessary after biological aortic valve replacement. Circulation 1998; II-95–II-99.Google Scholar
- 11.Stroke Prevention in Atrial Fibrillation Investigators. SPAF Study final results. Circulation 1991;84:527–539.Google Scholar
- 16.Stoke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation:I. Clinical features of patients at risk. Ann Intern med 1992;116:1–5.Google Scholar
- 17.Stroke Prevention in Atrial Fibrillation Investigators. Warfarin vs. aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in atrial Fibrillation II Study. Lancet 1994;343:687–691.Google Scholar
- 18.Atrial Fibrillaton Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized clinical trials. Arch Int med 1994;54:1949–1957.Google Scholar
- 21.McAnulty JH, Rahimtoola SH. Antithrombotic therapy and valvular heart disease. In Hurst’s The Heart, 9 th Edition, Alexander R, Schlant R, Fuster V, ed.: McGraw-Hill Companies, Inc. 1998.Google Scholar
- 22.Stroke Prevention in Atrial Ribrillation Investigators. Predictors of thromboembolism in atrial fibrillation:II. Echocardiographic features of patients at risk. Annals Int med 1992;116:6–12.Google Scholar